- Home
- FPH vs RCKT Comparison
FPH vs RCKT Comparison
Compare FPH & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FPH | RCKT |
|---|---|---|
| Founded | 2009 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.0M | 340.9M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | FPH | RCKT |
|---|---|---|
| Price | $5.60 | $3.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $29.12 |
| AVG Volume (30 Days) | 205.5K | ★ 2.3M |
| Earning Date | 01-22-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.55 | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $193,904,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.35 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.42 | $2.19 |
| 52 Week High | $6.71 | $13.50 |
Technical Indicators
Market Signals| Indicator | FPH | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 32.41 | 52.89 |
| Support Level | $5.51 | $3.30 |
| Resistance Level | $5.77 | $3.65 |
| Average True Range (ATR) | 0.16 | 0.19 |
| MACD | -0.06 | 0.04 |
| Stochastic Oscillator | 10.22 | 67.16 |
Price Performance
Historical ComparisonAbout FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.